Esperion Therapeutics (ESPR) Sales of Property, Plant and Equipment (2012 - 2015)

Esperion Therapeutics (ESPR) Sales of Property, Plant and Equipment (2012 - 2015) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 10.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 344,333.70
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.60 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Esperion Therapeutics 799.30 Mn 643.14 Mn 45.53 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2015 15,000.00
Dec 31, 2015 15,000.00
Sep 30, 2015 3,000.00
Sep 30, 2015 3,000.00
Dec 31, 2013 10,000.00
Dec 31, 2013 10,000.00
Sep 30, 2013 135,000.00
Sep 30, 2013 135,000.00
Jun 30, 2013 55,000.00
Jun 30, 2013 55,000.00
Mar 31, 2013 1,000.00
Mar 31, 2013 1,000.00
Dec 31, 2012 -2,060.00
Dec 31, 2012 -2,060.00
Sep 30, 2012 2,560.00
Sep 30, 2012 2,560.00